Search clinical trials for: Checkpoint Kinase 1 Inhibitor
Total 104242 results
-
Eisai Inc.Merck Sharp & Dohme LLCCompletedThyroid CancerUnited States, Canada, Germany, Korea, Republic of, Spain, France, Australia, Belgium, Denmark, Israel, Italy, Poland, Romania, Russian Federation, Sweden, United Kingdom
-
Loxo Oncology, Inc.Eli Lilly and CompanyWithdrawnMultiple Sclerosis | Relapsing Multiple SclerosisUnited States, Puerto Rico
-
Eisai Co., Ltd.CompletedNeoplasms | Carcinoma | Neoplasms, Glandular and Epithelial | Carcinoma, HepatocellularJapan
-
Eisai Co., Ltd.Completed
-
University of MiamiNot yet recruitingMental Health Wellness 1United States
-
Northern Arizona UniversityNot yet recruitingMental Health Wellness 1
-
Portsmouth Hospitals NHS TrustUniversity of SouthamptonRecruiting
-
University of GuelphRecruiting
-
Instituto Nacional de Ciencias Medicas y Nutricion...CompletedGut Microbiota | GLP-1Mexico
-
The Hong Kong Polytechnic UniversityCompleted
-
Pontificia Universidad Catolica de ValparaisoCompletedCognitive Function 1, SocialChile
-
OIHANA SAGASTI ARRIENUniversidad Nacional de Educación a DistanciaActive, not recruitingMental Health Wellness 1Spain
-
University of Colorado, DenverCompleted
-
Massachusetts General HospitalCompleted
-
Milton S. Hershey Medical CenterThe Hollister Confidence FundCompleted
-
Universidade do PortoCompleted
-
The University of Hong KongThe Boys' and Girls' Clubs Association of Hong KongCompleted
-
University of Texas at AustinCompleted
-
Javier Garcia CampayoCompletedMental Health Wellness 1Spain
-
Wayne State UniversityBlue Cross Blue Shield of Michigan FoundationCompleted
-
Chonbuk National University HospitalCompletedCognitive Function 1, Social
-
Chung Shan Medical UniversityChanghua Christian HospitalCompletedMental Health Wellness 1Taiwan
-
University of AlbertaCASA: Child, Adolescent and Family Mental HealthCompletedMental Health Wellness 1Canada
-
Haruhiko FukudaMinistry of Health, Labour and Welfare, JapanCompleted
-
Zhejiang Cancer HospitalRecruitingHepatocellular Carcinoma | Oxaliplatin | TACE | Lenvatinib | Tislelizumab | PharmorubicinChina
-
Merck Sharp & Dohme LLCNot yet recruitingEsophageal Cancer | Esophageal Neoplasms | Gastroesophageal Adenocarcinoma | Gastroesophageal Junction
-
Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung Cancer (NSCLC)China, Turkey, Australia, United States, Chile, Taiwan, Denmark, France, Spain, Argentina, Italy, Netherlands, Thailand, Korea, Republic of, Czechia, Portugal, Canada, United Kingdom
-
Merck Sharp & Dohme LLCRecruiting
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompletedSquamous Cell CarcinomaCanada, United States, Australia, France, Germany, Israel, Mexico, Norway, Spain, United Kingdom
-
Merck Sharp & Dohme LLCActive, not recruitingSmall Cell Lung CarcinomaPoland, Russian Federation, United States, Australia, Austria, Canada, Hungary, Israel, Italy, Korea, Republic of, Spain, Switzerland
-
Merck Sharp & Dohme LLCModernaTX, Inc.RecruitingRenal Cell CarcinomaAustralia, United States, Canada, Chile, Taiwan, Argentina
-
Merck Sharp & Dohme LLCActive, not recruitingMelanomaCanada, United States, Australia, Belgium, Brazil, Chile, France, Germany, Israel, Italy, Japan, Poland, South Africa, Spain, Switzerland, United Kingdom
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingColorectal NeoplasmsUnited States, Argentina, Australia, Canada, China, Denmark, Germany, Israel, Japan, Korea, Republic of, Russian Federation, Spain, Taiwan, Turkey, United Kingdom
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedNon Small Cell Lung CancerUnited States, Poland, Germany, Russian Federation, Latvia, Ukraine
-
Columbia UniversityAlpha-1 FoundationTerminatedChronic Obstructive Pulmonary Disease | Acute Exacerbation Copd | Alpha-1 Anti-trypsin DeficiencyUnited States
-
Jiulongpo No.1 People's HospitalUnknown
-
Jiujiang No.1 People's HospitalUnknown
-
Yangzhou No.1 People's HospitalUnknown
-
Yangzhou No.1 People's HospitalCompleted
-
Yaounde Central HospitalUniversity of Yaounde 1CompletedHypertension | Diabetes Mellitus, Type 2Cameroon
-
Merck Sharp & Dohme LLCNot yet recruiting
-
Merck Sharp & Dohme LLCModernaTX, Inc.RecruitingBladder CancerCanada, New Zealand, Germany, Chile, Australia, United States, Poland, Spain, Sweden, France, Italy
-
Merck Sharp & Dohme LLCRecruitingAdvanced or Metastatic Solid TumorsCanada, Switzerland, United States
-
Merck Sharp & Dohme LLCRecruitingLung Neoplasms | Non-Small-Cell Lung CarcinomaUnited States, Brazil, Canada, Chile, China, Guatemala, Hong Kong, Hungary, Japan, Korea, Republic of, Malaysia, Mexico, Peru, Russian Federation, South Africa, Taiwan, Thailand, Ukraine, Romania, Dominican Republic, Philippines, ... and more
-
Merck Sharp & Dohme LLCGOG Foundation; European Network of Gynaecological Oncological Trial Groups...Active, not recruitingEndometrial NeoplasmsAustralia, United States, Germany, Israel, Korea, Republic of, Poland, Turkey, Belgium, Brazil, Canada, Chile, China, Czechia, Denmark, Finland, Hungary, Ireland, Italy, Japan, Netherlands, New Zealand, Norway, Russian Federation, Spain, Swed... and more
-
Merck Sharp & Dohme LLCRecruitingBreast NeoplasmsIsrael, United States, Taiwan, Hong Kong, Korea, Republic of, Switzerland, Costa Rica, Malaysia
-
Merck Sharp & Dohme LLCCompletedProstatic NeoplasmsUnited States, Argentina, Australia, Austria, Brazil, Canada, Chile, France, Germany, Ireland, Israel, Italy, Japan, Korea, Republic of, Netherlands, Russian Federation, Spain, Taiwan, United Kingdom, New Zealand
-
Second Affiliated Hospital, School of Medicine,...Zhejiang Cancer Hospital; Sun Yat-sen University; Ningbo Medical Center Lihuili... and other collaboratorsRecruitingPlaque, Atherosclerotic | Programmed Cell Death Protein 1 InhibitorChina